UroMems is a series b startup based in France. 1 investor tracked.
UroMems is a company headquartered in France. Its most recent tracked round is Series-c-plus. Brouky records 4 investors associated with the company.
UroMems develops smart active implantable medical devices, such as the UroActive system, to treat stress urinary incontinence (SUI) in both men and women using microelectromechanical systems (MEMS) technology for automated urethral pressure control based on patient activity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.